m law group advises QureInvest in financing round of Medovent GmbH
m law group advises QureInvest in a financing round of Medovent GmbH.
QureInvest is a fund investing equity in biotech and life science businesses with a focus on seed and early stage companies.
Medovent develops and manufactures chitin and chitosan based biopolymers for stents, implants and other medical products. The company's corporate headquarters and research facility are located in Mainz.
Counsel to QureInvest:
m law group, Munich: Dr. Hubert Besner, Dr. Florian Anselm
Counsel to Medovent GmbH:
Pöllath + Partners, Munich: Christian Tönies LL.M.